Abbott Laboratories
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27.39B | $20.85B | $20.41B | $20.25B | $19.66B | $19.05B | $21.41B | $35.17B |
| Established Pharmaceutical Products | $4.29B | $3.86B | — | — | — | — | — | — |
| Nutritional Products | $6.93B | $6.90B | — | — | — | — | — | — |
| Diagnostic Products | $5.62B | $4.81B | — | — | — | — | — | — |
| Vascular Products | — | $2.90B | — | — | — | — | — | — |
| Medical Devices | $10.33B | — | — | — | — | — | — | — |
| Other | $237.0M | $2.39B | — | — | — | — | — | — |
| Cost of Revenue | $12.41B | $9.09B | $8.75B | $9.22B | $9.19B | $8.90B | $10.02B | $14.67B |
| Gross Profit | $14.98B | $11.76B | $11.66B | $11.03B | $10.46B | $10.15B | $11.39B | $20.50B |
| Gross Margin | 54.7% | 56.4% | 57.1% | 54.5% | 53.2% | 53.3% | 53.2% | 58.3% |
| Operating Expenses | ||||||||
| Research & Development | $2.26B | — | — | — | — | — | — | — |
| SG&A Expense | $9.18B | $6.74B | $6.79B | $6.53B | $6.37B | $6.74B | $7.37B | $10.38B |
| Operating Income | $1.56B | $3.03B | $2.87B | $2.60B | $2.13B | $1.36B | $1.63B | $6.09B |
| Operating Margin | 5.7% | 14.5% | 14.1% | 12.8% | 10.9% | 7.1% | 7.6% | 17.3% |
| Interest Expense | $904.0M | $431.0M | $163.0M | $150.0M | $145.0M | $320.0M | $359.0M | $553.1M |
| Pretax Income | $2.23B | $1.41B | $3.18B | $2.52B | $2.04B | $-220.0M | $1.24B | $5.71B |
| Income Tax Expense | $1.88B | $350.0M | $577.0M | $797.0M | $53.0M | $-457.0M | $110.0M | $1.09B |
| Net Income | $477.0M | $1.40B | $4.42B | $2.28B | $2.58B | $5.96B | $4.73B | $4.63B |
| Net Margin | 1.7% | 6.7% | 21.7% | 11.3% | 13.1% | 31.3% | 22.1% | 13.2% |
| EPS (Basic) | $0.27 | $0.94 | $2.94 | $1.50 | $1.64 | $3.76 | $3.03 | $2.98 |
| EPS (Diluted) | $0.27 | $0.94 | $2.92 | $1.49 | $1.62 | $3.72 | $3.01 | $2.96 |
| Shares Outstanding (Basic) | 1.74B | 1.48B | 1.50B | 1.52B | 1.56B | 1.58B | 1.56B | 1.55B |
| Shares Outstanding (Diluted) | 1.75B | 1.48B | 1.51B | 1.53B | 1.57B | 1.59B | 1.57B | 1.56B |
| Dividends Per Share | — | — | — | — | — | — | $1.92 | $1.76 |